Company
Headquarters: Tokyo, Japan
Employees: 3,291
CEO: Mr. Kotaro Fukuda
¥207.85 Billion
JPY as of Jan. 1, 2025
US$1.32 Billion
| Company | Market Cap (USD) |
|---|---|
| Abbott | $213.72 B |
| Stryker | $150.01 B |
| Boston Scientific Corporation | $149.80 B |
| Medtronic | $114.44 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Fukuda Denshi Co., Ltd. develops, manufactures, and sells medical electronic equipment worldwide. It provides resting electrocardiograph products; data management software; stress test products; Holter products and software; and patient monitoring systems, including central and bedside monitors, digital transmitters, and central viewer workstations. The company also offers defibrillator monitors; and ultrasound systems, as well as vascular screening systems. Fukuda Denshi Co., Ltd. was founded in 1939 and is based in Tokyo, Japan.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
| Last Financial Reports Date | June 30, 2024 |
| Revenue TTM | ¥138.10 B |
| EBITDA | ¥36.66 B |
| Gross Profit TTM | ¥74.45 B |
| Profit Margin | 12.01% |
| Operating Margin | 18.07% |
| Quarterly Revenue Growth | -9.10% |
Fukuda Denshi Co. Ltd has the following listings and related stock indices.
Stock: JPX: 6960 wb_incandescent